PDCT-05. MOLECULAR DIAGNOSTICS REVEAL 60% HIGHER SURVIVAL FOR MOLECULARLY-VERIFIED VERSUS HISTOPATHOLOGICALLY-DIAGNOSED PEDIATRIC SUPRATENTORIAL CENTRAL NERVOUS SYSTEM EMBRYONAL TUMORS AND PINEOBLASTOMAS; A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP ACNS0332 TRIAL

BACKGROUND: Children with high-risk medulloblastoma, supratentorial primitive neuroectodermal tumors (CNS-PNETs) and pineoblastomas (PBLs) have had poor survival despite intensive treatment. The Children’s Oncology Group trial ACNS0332 evaluated the efficacy of adding carboplatin or isotretinoin to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Hwang, Eugene, Kool, Marcel, Burger, Peter, Capper, David, Chavez, Lukas, Brabetz, Sebastian, Williams-Hughes, Chris, Billups, Catherine, Heier, Linda, Jaju, Alok, Michalski, Jeff, Li, Yimei, Zhou, Tianni, Leary, Sarah, Heideman, Nancy, von Deimling, Andreas, Jones, David, Gajjar, Amar, Packer, Roger, Pfister, Stefan M, Olson, James
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692459/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.749
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados